ENTRY       D10199                      Drug
NAME        Tapentadol hydrochloride (JAN);
            Nucynta (TN)
PRODUCT     NUCYNTA (Collegium Pharmaceutical)
            NUCYNTA (Collegium Pharmaceutical)
FORMULA     C14H23NO. HCl
EXACT_MASS  257.1546
MOL_WEIGHT  257.7995
CLASS       Neuropsychiatric agent
             DG01564  Opioid receptor agonist
              DG01563  mu-Opioid receptor agonist
            Analgesic
             DG01984  Opioid analgesics
            Metabolizing enzyme substrate
             DG02924  UGT substrate
REMARK      Therapeutic category: 8219
            ATC code: N02AX06
            Chemical structure group: DG00826
            Product (DG00826): D10199<JP/US>
EFFICACY    Analgesic, Opioid receptor agonist, Noradrenaline reuptake inhibitor
  DISEASE   Diabetic peripheral neuropathy (DPN) [DS:H01459]
TARGET      OPRM1 [HSA:4988] [KO:K04215]
            SLC6A2 (NAT1) [HSA:6530] [KO:K05035]
  PATHWAY   hsa04080(4988)  Neuroactive ligand-receptor interaction
            hsa04721(6530)  Synaptic vesicle cycle
METABOLISM  Enzyme: UGT [KO:K00699]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N02 ANALGESICS
               N02A OPIOIDS
                N02AX Other opioids
                 N02AX06 Tapentadol
                  D10199  Tapentadol hydrochloride (JAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Analgesics
              Opioid Analgesics, Long-acting
               Tapentadol
                D10199  Tapentadol hydrochloride (JAN)
              Opioid Analgesics, Short-acting
               Tapentadol
                D10199  Tapentadol hydrochloride (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             8  Narcotics
              82  Non-alkaloidal narcotics
               821  Synthetic narcotics
                8219  Others
                 D10199  Tapentadol hydrochloride (JAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01564  Opioid receptor agonist
               DG01563  mu-Opioid receptor agonist
                DG00826  Tapentadol
                 D10199  Tapentadol hydrochloride
             Analgesic
              DG01984  Opioid analgesics
               DG00826  Tapentadol
                D10199  Tapentadol hydrochloride
             Metabolizing enzyme substrate
              DG02924  UGT substrate
               DG00826  Tapentadol
                D10199  Tapentadol hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Opioid
                OPRM1
                 D10199  Tapentadol hydrochloride (JAN) &lt;JP/US&gt;
             Transporters
              Solute carrier family
               SLC6
                SLC6A2 (NAT1)
                 D10199  Tapentadol hydrochloride (JAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10199
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10199
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10199
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10199
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01564  Opioid receptor agonist
               DG01563  mu-Opioid receptor agonist
                DG00826  Tapentadol
             Analgesic
              DG01984  Opioid analgesics
               DG00826  Tapentadol
             Metabolizing enzyme substrate
              DG02924  UGT substrate
               DG00826  Tapentadol
DBLINKS     CAS: 175591-09-0
            PubChem: 163312232
ATOM        17
            1   C8y C    17.4300  -17.0800
            2   C8x C    17.4300  -18.4800
            3   C8x C    18.6200  -19.1800
            4   C8x C    19.8800  -18.4800
            5   C8y C    19.8800  -17.0800
            6   C8x C    18.6200  -16.3800
            7   O1a O    16.1700  -16.3800
            8   C1c C    21.0700  -16.3800
            9   C1c C    22.2600  -17.0800
            10  C1b C    21.0700  -14.9800
            11  C1b C    23.4500  -16.3800
            12  C1a C    22.2600  -14.2800
            13  N1c N    24.6400  -17.0800
            14  C1a C    22.2600  -18.4800
            15  C1a C    25.9000  -16.3800
            16  C1a C    24.6400  -18.4800
            17  X   Cl   29.3300  -18.6200
BOND        16
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     5   8 1
            9     8   9 1
            10    8  10 1 #Down
            11    9  11 1
            12   10  12 1
            13   11  13 1
            14    9  14 1 #Down
            15   13  15 1
            16   13  16 1
///
